IBRX
$9.18-8.20%
as of close, Oct 16, 2026
☾ AH $9.18 -8.20%
ImmunityBio Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.02%Russell 3000 0.005%US Stock Market 0.004%
ImmunityBio Inc. monthly returns
ImmunityBio Inc. has averaged 3.96% per month, positive in 41% of months. Month-by-month returns for ImmunityBio Inc. (IBRX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+4.0%
130 months
Best month
+215.7%
Jan 2026
Worst month
-49.2%
Dec 2024
Positive months
41%
of all months
ImmunityBio Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -2.8% | |
| Sep 2026 | +18.7% | |
| Aug 2026 | +10.9% | |
| Jul 2026 | -18.1% | |
| Jun 2026 | +16.4% | |
| May 2026 | +5.9% | |
| Apr 2026 | -7.4% | |
| Mar 2026 | -21.6% | |
| Feb 2026 | +56.5% | |
| Jan 2026 | +215.7% | |
| Dec 2025 | -16.1% | |
| Nov 2025 | -1.7% | |
| Oct 2025 | -2.4% | |
| Sep 2025 | +5.1% | |
| Aug 2025 | -4.9% | |
| Jul 2025 | -6.8% | |
| Jun 2025 | -0.8% | |
| May 2025 | +6.0% | |
| Apr 2025 | -16.6% | |
| Mar 2025 | -8.5% | |
| Feb 2025 | -4.6% | |
| Jan 2025 | +34.8% | |
| Dec 2024 | -49.2% | |
| Nov 2024 | -3.3% | |
| Oct 2024 | +40.1% | |
| Sep 2024 | -5.8% | |
| Aug 2024 | -23.3% | |
| Jul 2024 | -18.5% | |
| Jun 2024 | -1.6% | |
| May 2024 | -19.6% | |
| Apr 2024 | +48.8% | |
| Mar 2024 | +13.5% | |
| Feb 2024 | +40.8% | |
| Jan 2024 | -33.1% | |
| Dec 2023 | +36.4% | |
| Nov 2023 | +17.2% | |
| Oct 2023 | +85.8% | |
| Sep 2023 | +5.0% | |
| Aug 2023 | -26.8% | |
| Jul 2023 | -20.9% | |
| Jun 2023 | +1.1% | |
| May 2023 | -1.8% | |
| Apr 2023 | +53.8% | |
| Mar 2023 | -25.4% | |
| Feb 2023 | -35.8% | |
| Jan 2023 | -25.0% | |
| Dec 2022 | -8.0% | |
| Nov 2022 | +0.2% | |
| Oct 2022 | +10.7% | |
| Sep 2022 | +24.3% | |
| Aug 2022 | +2.8% | |
| Jul 2022 | +4.6% | |
| Jun 2022 | -1.1% | |
| May 2022 | +3.6% | |
| Apr 2022 | -35.3% | |
| Mar 2022 | -18.0% | |
| Feb 2022 | +17.5% | |
| Jan 2022 | -4.3% | |
| Dec 2021 | -22.0% | |
| Nov 2021 | -0.5% | |
| Oct 2021 | -19.6% | |
| Sep 2021 | -14.4% | |
| Aug 2021 | +3.8% | |
| Jul 2021 | -23.2% | |
| Jun 2021 | -18.6% | |
| May 2021 | -1.1% | |
| Apr 2021 | -25.2% | |
| Mar 2021 | -27.0% | |
| Feb 2021 | +72.2% | |
| Jan 2021 | +41.6% | |
| Dec 2020 | +39.1% | |
| Nov 2020 | +27.6% | |
| Oct 2020 | +8.3% | |
| Sep 2020 | -5.0% | |
| Aug 2020 | -34.7% | |
| Jul 2020 | -9.0% | |
| Jun 2020 | +82.2% | |
| May 2020 | +72.8% | |
| Apr 2020 | +35.4% | |
| Mar 2020 | -40.5% | |
| Feb 2020 | -23.4% | |
| Jan 2020 | +66.8% | |
| Dec 2019 | +120.3% | |
| Nov 2019 | +63.8% | |
| Oct 2019 | -13.9% | |
| Sep 2019 | -6.2% | |
| Aug 2019 | -5.8% | |
| Jul 2019 | +35.3% | |
| Jun 2019 | -1.0% | |
| May 2019 | -8.0% | |
| Apr 2019 | -29.1% | |
| Mar 2019 | +39.8% | |
| Feb 2019 | +4.6% | |
| Jan 2019 | -6.9% | |
| Dec 2018 | -32.2% | |
| Nov 2018 | -21.6% | |
| Oct 2018 | -41.1% | |
| Sep 2018 | +9.1% | |
| Aug 2018 | -3.1% | |
| Jul 2018 | +14.4% | |
| Jun 2018 | -16.4% | |
| May 2018 | -6.2% | |
| Apr 2018 | +0.3% | |
| Mar 2018 | -12.4% | |
| Feb 2018 | +0.5% | |
| Jan 2018 | -1.6% | |
| Dec 2017 | -8.4% | |
| Nov 2017 | +6.1% | |
| Oct 2017 | -15.7% | |
| Sep 2017 | -12.0% | |
| Aug 2017 | -3.6% | |
| Jul 2017 | -14.9% | |
| Jun 2017 | +106.8% | |
| May 2017 | +16.5% | |
| Apr 2017 | -11.3% | |
| Mar 2017 | -24.9% | |
| Feb 2017 | -11.8% | |
| Jan 2017 | -6.3% | |
| Dec 2016 | -12.5% | |
| Nov 2016 | +9.2% |
Monthly total return (since Nov 2021)#
-200%-100%0%100%200%
Nov 2021-0.51%
Dec 2021-22%
Jan 2022-4.3%2022
Feb 2022+18%
Mar 2022-18%
Apr 2022-35%
May 2022+3.6%
Jun 2022-1.1%
Jul 2022+4.6%
Aug 2022+2.8%
Sep 2022+24%
Oct 2022+11%
Nov 2022+0.18%
Dec 2022-8.0%
Jan 2023-25%2023
Feb 2023-36%
Mar 2023-25%
Apr 2023+54%
May 2023-1.8%
Jun 2023+1.1%
Jul 2023-21%
Aug 2023-27%
Sep 2023+5.0%
Oct 2023+86%
Nov 2023+17%
Dec 2023+36%
Jan 2024-33%2024
Feb 2024+41%
Mar 2024+14%
Apr 2024+49%
May 2024-20%
Jun 2024-1.6%
Jul 2024-19%
Aug 2024-23%
Sep 2024-5.8%
Oct 2024+40%
Nov 2024-3.3%
Dec 2024-49%
Jan 2025+35%2025
Feb 2025-4.6%
Mar 2025-8.5%
Apr 2025-17%
May 2025+6.0%
Jun 2025-0.75%
Jul 2025-6.8%
Aug 2025-4.9%
Sep 2025+5.1%
Oct 2025-2.4%
Nov 2025-1.7%
Dec 2025-16%
Jan 2026+216%2026
Feb 2026+56%
Mar 2026-22%
Apr 2026-7.4%
May 2026+5.9%
Jun 2026+16%
Jul 2026-18%
Aug 2026+11%
Sep 2026+19%
Oct 2026-2.8%
ImmunityBio Inc. returns by calendar month#
Every month of every year since 2016, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -2.75% — 6th of 11 Octobers since 2016 at the last close; the average October returned +2.9%.
| Month | −220%0+220% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +21.9% | -4.3% | 36% | +215.7% 2026 | -40.6% 2016 | |
| Feb | +7.6% | +0.5% | 55% | +72.2% 2021 | -35.8% 2023 | |
| Mar | -9.6% | -18.0% | 27% | +39.8% 2019 | -40.5% 2020 | |
| Apr | +1.3% | -7.4% | 45% | +53.8% 2023 | -35.3% 2022 | |
| May | +5.5% | -1.1% | 45% | +72.8% 2020 | -19.6% 2024 | |
| Jun | +13.5% | -1.0% | 36% | +106.8% 2017 | -18.6% 2021 | |
| Jul | -4.3% | -9.0% | 36% | +35.3% 2019 | -23.2% 2021 | |
| Aug | -6.0% | -3.6% | 36% | +18.4% 2016 | -34.7% 2020 | |
| Sep | +1.4% | -3.8% | 45% | +24.3% 2022 | -14.4% 2021 | |
| Oct | +2.9% | -8.2% | 40% | +85.8% 2023 | -41.1% 2018 | |
| Nov | +9.7% | +3.1% | 60% | +63.8% 2019 | -21.6% 2018 | |
| Dec | +4.8% | -10.5% | 30% | +120.3% 2019 | -49.2% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from IBRX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is ImmunityBio Inc.'s average monthly return?
- ImmunityBio Inc. (IBRX) has averaged about 3.96% per month, positive in roughly 41% of months. The best month was Jan 2026 (+215.7%) and the worst was Dec 2024 (-49.2%).
More on ImmunityBio Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100